Results 191 to 200 of about 4,044,052 (294)
Medicare Plan Switching and Hospice Care Among Decedents With Advanced Cancer.
Hu X +10 more
europepmc +1 more source
Diversity-sensitive palliative and hospice care in Germany - awareness, attitudes, and measures taken by service providers. [PDF]
Erdsiek F +3 more
europepmc +1 more source
ABSTRACT Canine cancer imposes substantial emotional, financial and decisional burden on owners navigating complex referral pathways and treatment options. Understanding how owners experience and interpret these pathways is essential to improving care delivery.
Georgina Anne Tarrant +5 more
wiley +1 more source
Improving Eye Donation Discussions in a Hospice Care Setting: A Quality Improvement Initiative. [PDF]
MacInnes E.
europepmc +1 more source
Amyloid β alters vascular CaV1.2 channel spatiotemporal properties
Abstract figure legend Amyloid‐β1‐42 (Aβ1‐42) triggers a male‐specific signalling cascade influencing CaV1.2 spatiotemporal properties in cerebral vascular smooth muscle. The signalling pathway involves NADPH oxidase (NOX)‐derived reactive oxygen species (ROS) activation of protein kinase C (PKC). Aβ1‐42 can also activate protein kinase A (PKA).
Jade L. Taylor +5 more
wiley +1 more source
Hospice care for Medicaid cancer patients in Puerto Rico: implications on healthcare costs and utilization. [PDF]
Ortiz-Ortiz KJ +7 more
europepmc +1 more source
ABSTRACT As population aging accelerates, the coexistence of cancer and Alzheimer's disease and related dementias (ADRD) is becoming increasingly common. While each condition independently contributes to mortality, national trends in cancer‐related deaths occurring alongside ADRD—and their demographic and geographic disparities—remain poorly defined ...
Aasim Ali +14 more
wiley +1 more source
Utilizing Pharmacogenetic Results to Optimize Medication Management in Hospice Care: A Pilot Study. [PDF]
Dreikorn EN +7 more
europepmc +1 more source
ABSTRACT Background Autosomal dominant centronuclear myopathy (ADCNM), most commonly caused by mutations in the dynamin 2 (DNM2) gene, is a rare congenital myopathy characterized by progressive muscle weakness and atrophy. Myostatin, a key negative regulator of skeletal muscle mass, has shown therapeutic potential in several models of neuromuscular ...
Durieux Anne‐Cécile +20 more
wiley +1 more source

